154 related articles for article (PubMed ID: 37078771)
1. Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical Trial.
D'Angelica MI; Ellis RJ; Liu JB; Brajcich BC; Gönen M; Thompson VM; Cohen ME; Seo SK; Zabor EC; Babicky ML; Bentrem DJ; Behrman SW; Bertens KA; Celinski SA; Chan CHF; Dillhoff M; Dixon MEB; Fernandez-Del Castillo C; Gholami S; House MG; Karanicolas PJ; Lavu H; Maithel SK; McAuliffe JC; Ott MJ; Reames BN; Sanford DE; Sarpel U; Scaife CL; Serrano PE; Smith T; Snyder RA; Talamonti MS; Weber SM; Yopp AC; Pitt HA; Ko CY
JAMA; 2023 May; 329(18):1579-1588. PubMed ID: 37078771
[TBL] [Abstract][Full Text] [Related]
2. Association Between Biliary Pathogens, Surgical Site Infection, and Pancreatic Fistula: Results of a Randomized Trial of Perioperative Antibiotic Prophylaxis in Patients Undergoing Pancreatoduodenectomy.
Ellis RJ; Brajcich BC; Bertens KA; Chan CHF; Castillo CF; Karanicolas PJ; Maithel SK; Reames BN; Weber SM; Vidri RJ; Pitt HA; Thompson VM; Gonen M; Seo SK; Yopp AC; Ko CY; D'Angelica MI
Ann Surg; 2023 Sep; 278(3):310-319. PubMed ID: 37314221
[TBL] [Abstract][Full Text] [Related]
3. Cefoxitin versus piperacillin-tazobactam as surgical antibiotic prophylaxis in patients undergoing pancreatoduodenectomy: protocol for a randomised controlled trial.
Nevarez NM; Brajcich BC; Liu J; Ellis R; Ko CY; Pitt HA; D'Angelica MI; Yopp AC
BMJ Open; 2021 Mar; 11(3):e048398. PubMed ID: 33664081
[TBL] [Abstract][Full Text] [Related]
4. Perioperative antibiotics for surgical site infection in pancreaticoduodenectomy: does the SCIP-approved regimen provide adequate coverage?
Donald GW; Sunjaya D; Lu X; Chen F; Clerkin B; Eibl G; Li G; Tomlinson JS; Donahue TR; Reber HA; Hines OJ
Surgery; 2013 Aug; 154(2):190-6. PubMed ID: 23664266
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic Prophylaxis with Piperacillin-Tazobactam Reduces Post-Operative Infectious Complication after Pancreatic Surgery: An Interventional, Non-Randomized Study.
De Pastena M; Paiella S; Azzini AM; Zaffagnini A; Scarlini L; Montagnini G; Maruccio M; Filippini C; Romeo F; Mazzariol A; Cascio GL; Bazaj A; Secchettin E; Bassi C; Salvia R
Surg Infect (Larchmt); 2021 Jun; 22(5):536-542. PubMed ID: 33095107
[No Abstract] [Full Text] [Related]
6. Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.
Harris PNA; Tambyah PA; Lye DC; Mo Y; Lee TH; Yilmaz M; Alenazi TH; Arabi Y; Falcone M; Bassetti M; Righi E; Rogers BA; Kanj S; Bhally H; Iredell J; Mendelson M; Boyles TH; Looke D; Miyakis S; Walls G; Al Khamis M; Zikri A; Crowe A; Ingram P; Daneman N; Griffin P; Athan E; Lorenc P; Baker P; Roberts L; Beatson SA; Peleg AY; Harris-Brown T; Paterson DL;
JAMA; 2018 Sep; 320(10):984-994. PubMed ID: 30208454
[TBL] [Abstract][Full Text] [Related]
7. [Perioperative antibiotic prophylaxis in radical retropubic prostatectomy: a randomised pilot study of perioperative and postoperative administration].
Schenck M; Luetzke A; Ruebben H; Schneider T
Aktuelle Urol; 2011 Jan; 42(1):38-45. PubMed ID: 21267804
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic prophylaxis with piperacillin-tazobactam reduces organ/space surgical site infection after pancreaticoduodenectomy: a retrospective and propensity score-matched analysis.
Yang Y; Sheng J; Cai Z; Zhu L; Lu C; Mao L; Qiu Y; Fu X
BMC Cancer; 2024 Feb; 24(1):251. PubMed ID: 38395787
[TBL] [Abstract][Full Text] [Related]
9. Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection: The ACORN Randomized Clinical Trial.
Qian ET; Casey JD; Wright A; Wang L; Shotwell MS; Siemann JK; Dear ML; Stollings JL; Lloyd BD; Marvi TK; Seitz KP; Nelson GE; Wright PW; Siew ED; Dennis BM; Wrenn JO; Andereck JW; Han JH; Self WH; Semler MW; Rice TW;
JAMA; 2023 Oct; 330(16):1557-1567. PubMed ID: 37837651
[TBL] [Abstract][Full Text] [Related]
10. Piperacillin-Tazobactam vs Cefoxitin Prophylaxis for Pancreatoduodenectomy.
Sawyer RG
JAMA; 2023 Sep; 330(11):1098-1099. PubMed ID: 37721617
[No Abstract] [Full Text] [Related]
11. Piperacillin-Tazobactam vs Cefoxitin Prophylaxis for Pancreatoduodenectomy.
Yang Z; Mei J; Gong W
JAMA; 2023 Sep; 330(11):1098. PubMed ID: 37721616
[No Abstract] [Full Text] [Related]
12. Piperacillin-Tazobactam vs Cefoxitin Prophylaxis for Pancreatoduodenectomy.
Jouffroy R; Lupinacci RM; Dournon N
JAMA; 2023 Sep; 330(11):1097-1098. PubMed ID: 37721615
[No Abstract] [Full Text] [Related]
13. Piperacillin/Tazobactam versus Tobramycin-Based Antibiotic Prophylaxis for Type III Open Fractures.
Shawar SK; Ly TV; Li J; Shirk MB; Reichert EM
Surg Infect (Larchmt); 2020 Feb; 21(1):23-28. PubMed ID: 31381489
[No Abstract] [Full Text] [Related]
14. Piperacillin-Tazobactam vs Cefoxitin Prophylaxis for Pancreatoduodenectomy-Reply.
Ellis RJ; Ko CY; D'Angelica MI
JAMA; 2023 Sep; 330(11):1099-1100. PubMed ID: 37721612
[No Abstract] [Full Text] [Related]
15. Effect of Cefepime/Enmetazobactam vs Piperacillin/Tazobactam on Clinical Cure and Microbiological Eradication in Patients With Complicated Urinary Tract Infection or Acute Pyelonephritis: A Randomized Clinical Trial.
Kaye KS; Belley A; Barth P; Lahlou O; Knechtle P; Motta P; Velicitat P
JAMA; 2022 Oct; 328(13):1304-1314. PubMed ID: 36194218
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study.
Réa-Neto A; Niederman M; Lobo SM; Schroeder E; Lee M; Kaniga K; Ketter N; Prokocimer P; Friedland I
Curr Med Res Opin; 2008 Jul; 24(7):2113-26. PubMed ID: 18549664
[TBL] [Abstract][Full Text] [Related]
17. Surgical Site Infections in Patients With Type 3 Open Fractures: Comparing Antibiotic Prophylaxis With Cefazolin Plus Gentamicin Versus Piperacillin/Tazobactam.
Redfern J; Wasilko SM; Groth ME; McMillian WD; Bartlett CS
J Orthop Trauma; 2016 Aug; 30(8):415-9. PubMed ID: 26825490
[TBL] [Abstract][Full Text] [Related]
18. Extended antibiotic therapy is associated with a lower rate of clinically relevant postoperative pancreatic fistula after pancreatoduodenectomy in intermediate- and high-risk patients: A single-institution analysis.
Ocuin LM; Loftus A; Elshami M; Hue JJ; Musonza T; Ammori JB; Winter JM; Hardacre JM
Surgery; 2024 Feb; 175(2):477-483. PubMed ID: 37940433
[TBL] [Abstract][Full Text] [Related]
19. Perioperative antibiotherapy should replace prophylactic antibiotics in patients undergoing pancreaticoduodenectomy preceded by preoperative biliary drainage.
Degrandi O; Buscail E; Martellotto S; Gronnier C; Collet D; Adam JP; Ouattara A; Laurent C; Dewitte A; Chiche L
J Surg Oncol; 2019 Sep; 120(4):639-645. PubMed ID: 31297827
[TBL] [Abstract][Full Text] [Related]
20. A NSQIP-based randomized clinical trial evaluating choice of prophylactic antibiotics for pancreaticoduodenectomy.
Brajcich BC; Ko CY; Liu JB; Ellis RJ; D Angelica MI
J Surg Oncol; 2021 May; 123(6):1387-1394. PubMed ID: 33831250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
